BMC Medical Co. Ltd. A (301367) — Capital Reinvestment Ratio
BMC Medical Co. Ltd. A (301367) has a Capital Reinvestment Ratio of 0.25x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥130.16 Million) in capital expenditures (CN¥32.22 Million). See BMC Medical Co. Ltd. A net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
BMC Medical Co. Ltd. A Capital Reinvestment Ratio (2020–2025)
This chart tracks BMC Medical Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods. Check 301367 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for BMC Medical Co. Ltd. A (2020–2025)
Year-by-year Capital Reinvestment Ratio for BMC Medical Co. Ltd. A from 2020 to 2025. For live market cap and broader valuation context, see BMC Medical Co. Ltd. A market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | CN¥130.16 Million | CN¥32.22 Million | ▲ +139.5% |
| 2024 | 0.10x | CN¥154.08 Million | CN¥15.93 Million | ▼ -35.3% |
| 2023 | 0.16x | CN¥151.11 Million | CN¥24.12 Million | ▲ +152.3% |
| 2022 | 0.06x | CN¥375.21 Million | CN¥23.75 Million | ▼ -34.1% |
| 2021 | 0.10x | CN¥104.40 Million | CN¥10.03 Million | ▲ +66.5% |
| 2020 | 0.06x | CN¥267.41 Million | CN¥15.43 Million | — |